Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why NIO down ?
A possible price of $ 300 that some announce is only a strong opportunity to buy. So much and nothing more. But unfortunately for us we will not end up buying at that price.I would love to.
TSLA, AAPL - they are the future. If you want to invest in them, don't think about the present. The gain that the short ones claim to have made through the sale is much lower, I assure you.But this is much less important - the short ones often confuse the market with the casino and end up losing a lot of money.
Tesla stock price target raised to $550 from $350 at BofA Securities
Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-Efficient and In Vivo Production of Antibody Therapeutics in Patients
9:00 am ET September 2, 2020 (Globe Newswire) Print
Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") and SmartPharm Therapeutics, Inc. ("SmartPharm") announced today that Sorrento has completed the acquisition of SmartPharm, a gene-encoded protein therapeutics company developing non-viral DNA and RNA gene delivery platforms for COVID-19 and rare diseases with broad potential application in enhancing any antibody-centric therapeutics.
The platform in synergy with Sorrento's industry-leading fully human G-MAB(TM) antibody library has the potential to be the engine for the next-generation, cost-effective in vivo production of antibody therapeutics in patients. By encoding the antibody sequence into a plasmid, a single injection into someone's muscle could potentially lead the person to make their own antibodies in vivo for months, instead of relying on repeat administrations of an externally manufactured antibody.
"We are very encouraged by the preclinical data generated thus far by our STI-2020dna plasmid candidate against COVID-19," said Henry Ji, Ph.D., CEO of Sorrento Therapeutics. "But beyond STI-2020dna the integration of the plasmid DNA technology with our existing antibody products has the potential to make antibody therapy much more accessible and affordable for patients, and is applicable to a multitude of indications ranging from cancer to infectious diseases."
The current SmartPharm R&D and senior management team will remain in place and is expected to integrate into the Sorrento research, development, and corporate infrastructure.
The merger was completed on September 1, 2020 and at such time, SmartPharm became a wholly owned subsidiary of Sorrento. The total value of the consideration payable to the holders of capital stock of SmartPharm in the merger was $19.4 million, subject to certain adjustments for net working capital, indebtedness, transaction expenses and cash. Upon completion of the merger, SmartPharm stockholders became entitled to receive an aggregate of approximately 1.76 million shares of Sorrento common stock based on a price per share equal to $10.60.
On way to 140 $ today and around 200 $ by the end of this year- the best stock for retirement
Tomorrow to 20.50 $ - the last upgrade from MS bank
$ 481 after hours -
$ 32.38 $ after hours - on way to 34 $
$ 135 hit after hours - tomorrow maybe 140 $
True - well pointed.
Premarket
That's how it is and I think that's how investors understood it. We've been talking about a little over 10 million shares.It's hard for me to believe that someone made such a mess.But clarification is welcome.
These can only be considered false statements when the FDA rejects all of their treatments.Until then, we are only talking about some scientific research that is awaiting approval - this is the case with all biotech stocks.
Several of Rocket’s IPO underwriters finally weighed in on the stock on Monday following their mandatory quiet period:
Wells Fargo has an Equal-Weight rating and $29 target.
RBC Capital Markets has an Outperform rating and $32 target.
Morgan Stanley has an Equal-Weight rating and $25 target.
Citi has a Buy rating and $35 target.
Thanks - only at night after 11 pm.
20.05 $ - nice day -$$$$$$$$$$$
Me too
He doesn't want to say ELON - I like your insistence -
30.90 $ - nice day
Apple stock price target raised to $140.00 from $117.50 at at BofA Securities
That's right - I already bought in this morning - depending on the price I will continue to buy for AAPL and TSLA
Watch this video about saliva test
My hopes are only related to a possible FDA approval and this only because I personally believe in their research. It is true that this trust derives only from articles found on various sites or medical publications.Otherwise I am not a specialist in the field and of course these assessments of mine can be wrong.
No, such items are certainly not paid for here - maybe on other sites yes, but not here. It is true that all investors would like more information from them and do not understand why the CEO is so retained in the information. Until any FDA announcement ... just hope.
No, such items are certainly not paid for here - maybe on other sites yes, but not here. It is true that all investors would like more information from them and do not understand why the CEO is so retained in the information. Until any FDA announcement ... just hope.
Big day tomorrow $$$$$$$$
That's what he thinks ... and he also thinks that he can influence something through his posts. HAHAHAHAHAHA
posted by LN - "Tesla currently control 80% of US EV markets.
Two years ago, there were lot of doubts about Elon Musks ability to scale up, which Elon thought 1000% harder than start up.
Because ..need to hire more people, build factory, and capital intensive...
But after Giga factory Nevada, and Giga factory in Shanghai, there is no doubt now that he will be successful.
Tesla now open two more and start building Giga Texas and Giga Berlin...
Other ICE markers need to show up soon or the door will shut them out soon.
with battery day, Sep 22, Elon will unveil new battery technology then it's over.
and with 5 billions, Elon can open at least 3 more factories."